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Consent to medical procedures and outcome of medical mishaps'
The subject of patient consent and the satisfaction of compensation claims when medical procedures go wrong is very important in all forms of clinical practice. At a meeting on 27 January 1983 of the Royal Society of Medicine Library (Scientific Research) Section, papers were delivered which covered both the aspects of canvassing for consent and also the subtle nature and adequacy of compensation should procedures go wrong.
It was pointed out that the process of obtaining well-informed consent is, unfortunately, inadequate since those most needing to grant or refuse it are often those paradoxically in the least able position to give it. There are, Dr G F Birdwood (Ciba-Geigy Publications) said, numerous examples of such patients. One group includes patients needing urgent treatment, suffering severe pain or distress, the emotionally unstable or confused and patients under anaesthesia or other emergency treatment; a second group includes those unconscious, compulsorily treated under a care order and those compulsorily detained under the Mental Health Act; a third group includes those whose consent is simply not sought because of oversight, assumption, or fear of prejudicing the conduct of a clinical trial.
A second problem when seeking consent is that there is so much information available that is not actually much help in decision-making, but is useful when reinforcing experience. Since a patient may have little or no relevant experience, the best solution may be for an independent adviser to assist. This would also help with a third and general problemthe conflicting attitudes of doctor and patient.
Ultimately, as Mr A Simanowitz (Action for the Victims of Medical Accidents) pointed out, the debate on seeking consent is a legal one, as is that of assessing claims for compensation when a medical procedure goes wrong. However, compensation means not only a monetary ' Report of meeting of the Library (Scientific Research) Section, 27 January 1983. Accepted 11 January 1984 recompense but a satisfaction or putting right, and sometimes may include disciplinary action. It seems, from letters received from patients, that part of a patient's shock after such an accident stems directly from the injury received with its attendant pain or disability, but a large part is rooted in the wall of non-communication which replaces the previous concern for the patient's welfare. Just when a patient has suffered a major loss, he or she finds that the nursing and medical staff have no more to say. They may even become unpleasant. The desirability of expressing to the patient an attitude of sympathy and reassurance in such circumstances was emphasized. Though sympathetic treatment by doctors merely to head off possibly justified claims of negligence is certainly not condoned, some unnecessary legal proceedings might be avoided by a little time and effort being spent with a patient, acknowledging and explaining the problems of the case. Doctors find this very difficult because of their concern that their comments may be construed as evidence against colleagues, and yet the person in the position to help at that stage is the doctor. It is unacceptable that patients suffering injury at the hands of the medical profession should then be estranged by the profession.
The introduction of the no-fault compensation system may prove to be a major step forward, but, in the meantime, a different approach to patients who have suffered through negligence must be developed as-a matter of the highest priority.
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Section of Rheumatology & Rehabilitation: short papers'
The meeting opened with a paper on primary multifocal fibrositis and chronic benzodiazepine consumption, read by T Bitter for M Waidburger (Switzerland). Smyth (1981) proposed diagnostic criteria for the 'fibrositis syndrome' to include widespread aching pain which is burning in character and unrelieved by non-steroidal antiinflammatory drugs, diffuse local tenderness often at musculotendinous insertions and disturbance of the sleep pattern. In this limited study of 27 women presenting with this syndrome, 25 had been taking benzodiazepines (diazepam being the most well-known example) for up to 15 years. It is suggested that prolonged treatment with these drugs lowers the pain threshold, possibly by depletion of brain serotonin (Snyders et al. 1977) , with resulting depression of the stage IV (nonrapid-eye-movement) sleep pattern. From the audience, Dr A Crisp wondered whether hormonal replacement might help, as most of the women in the study were perimenopausal; this did not appear to be the case.
Dr T R Littler spoke for K R H Adams and L D C Halliday (Liverpool) on their experience with etretinate in polyarthritis and psoriasis. Etretinate is a synthetic derivative of vitamin A with similar biological activity and relatively less toxicity. In view of its known beneficial effect on psoriasis, and because retinol can affect mesenchymal as well as epithelial cells, its possible value in the treatment of psoriatic arthritis (5 patients), indeterminate seronegative arthritis with psoriasis (3 patients) and seropositive rheumatoid arthritis (2 patients) was studied. The dose was 50 mg daily for 2 months, then 25 mg daily for 4 months. The benefici4l effect of etretinate was confirmed. Encouraging results were also obtained in polyarthritis associated with psoriasis in the seronegative groups, but not in the seropositive rheumatoid patients. There were numerous side effects, especially cheilitis and hair loss. It was concluded that the drug could not be recommended for the treatment of polyarthritis with or without psoriasis in the dosage used in this study.
Dr T D Kennedy, for C S Higgins, D F Woodrow and J T Scott (London), gave a paper on crystal deposition in the knee and great toe joints of asymptomatic gout patients. Monosodium urate (MSU) crystals often remain in the synovial fluid or membrane long after an acute attack of gout has resolved (Scott 1978) . Crystals have been found in the synovial fluid of asymptomatic first metatarsophalangeal (MTP) joints (Weinberger et al. 1979) . In 31 patients with proven gout, arthroscopy of the knee (which had never been the site of acute gout) was performed. Crystalline material was seen in 9 (29%). Histology of the synovial membrane demonstrated MSU crystals in 3 and calcium pyrophosphate 'dihydrate (CPPD) crystals in one of the 31 biopsies studied. Synovial fluid was obtained from 27 of the knees; MSU crystals were seen in 4 (14%) and CPPD crystals in 2. Immediately following arthroscopy, the first MTP joint was aspirated. MSU crystals were demonstrated in 14 (52%) of the 27 samples
